Quest Diagnostics (DGX) EPS (Basic) (2009 - 2026)

Quest Diagnostics has disclosed EPS (Basic) across 18 years of filings, most recently posting $2.92 for Q2 2026.

• In Q2 2026, EPS (Basic) rose 13.91% year-over-year to $2.92; the TTM figure through Jun 2026 stood at $9.77 (up 13.23% YoY), while the FY2025 annual figure was $9.05, up 11.31% from the prior year.
• EPS (Basic) came in at $2.92 for Q2 2026 at Quest Diagnostics, up from $2.36 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $2.92 in Q2 2026 to a low of $0.97 in Q4 2022.
• Average EPS (Basic) over 5 years is $2.14, with a median of $2.13 recorded in 2023.
• Year-over-year, EPS (Basic) slumped 68.62% in 2022 and soared 80.56% in 2023.
• Over 5 years, EPS (Basic) stood at $0.97 in 2022, then soared by 80.56% to $1.76 in 2023, then climbed by 18.32% to $2.08 in 2024, then advanced by 7.79% to $2.24 in 2025, then surged by 30.12% to $2.92 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were $2.92 in Q2 2026, $2.36 in Q1 2026, and $2.24 in Q4 2025.